Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract CT014: Phase I dose-escalation study of fractionated dose 225Ac J591 for metastatic castration resistant prostate cancer

Cancer Res (2023) 83 (8_Supplement): CT014.

https://doi.org/10.1158/1538-7445.AM2023-CT014

Published: 14 April 2023

View article titled, Abstract CT014: Phase I dose-escalation study of fractionated dose 225Ac J591 for metastatic castration resistant prostate cancer

Journal Articles

Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)

Judy C. Boughey, Kari M. Rosenkranz, Karla V. Ballman, Linda McCall, Bruce G. Haffty, Laurie W. Cuttino, Charlotte D. Kubicky, H. T. Carisa Le-Petross, Kimberly Van Zee, Armando E. Giuliano, Olwen M. Hahn, Kelly K. Hunt, Lisa Carey, Ann Partridge

Cancer Res (2023) 83 (5_Supplement): GS4-01.

https://doi.org/10.1158/1538-7445.SABCS22-GS4-01

Published: 01 March 2023

View article titled, Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)

Journal Articles

Abstract 3407: Circulating tumor DNA is associated with response and survival in patients with advanced leiomyosarcoma

Laura Madanat-Harjuoja, Kelly Klega, Yao Lu, David S. Shulman, Aaron R. Thorner, Anwesha Nag, William Tap, Denise K. Reinke, Lisa Diller, Karla V. Ballman, Suzanne George, Brian D. Crompton

Cancer Res (2022) 82 (12_Supplement): 3407.

https://doi.org/10.1158/1538-7445.AM2022-3407

Published: 15 June 2022

View article titled, Abstract 3407: Circulating tumor DNA is associated with response and survival in patients with advanced leiomyosarcoma

Journal Articles

Abstract 494: Role of age, BMI, and tumor subtype in racial/ethnic disparities in breast cancer survival: A pooled analysis of four Alliance adjuvant clinical trials

Marla Lipsyc-Sharf, Karla V. Ballman, Jordan D. Campbell, Hyman B. Muss, Edith A. Perez, Lawrence N. Shulman, Lisa A. Carey, Ann H. Partridge, Erica T. Warner

Cancer Res (2022) 82 (12_Supplement): 494.

https://doi.org/10.1158/1538-7445.AM2022-494

Published: 15 June 2022

View article titled, Abstract 494: Role of age, BMI, and tumor subtype in racial/ethnic disparities in breast cancer survival: A pooled analysis of four Alliance adjuvant clinical trials

Journal Articles

Abstract S1-06: Stromal tumor-infiltrating lymphocytes(S-TILs): In the alliance N9831 trial S-TILs are associated with chemotherapy benefit but not associated with trastuzumab benefit

Edith A Perez, Karla V Ballman, S Keith Anderson, E Aubrey Thompson, Sunil S Badve, Helen Bailey, Frederick L Baehner

Cancer Res (2015) 75 (9_Supplement): S1-06.

https://doi.org/10.1158/1538-7445.SABCS14-S1-06

Published: 01 May 2015

View article titled, Abstract S1-06: Stromal tumor-infiltrating lymphocytes(S-TILs): In the alliance N9831 trial S-TILs are associated with chemotherapy benefit but not associated with trastuzumab benefit

Journal Articles

Abstract P2-01-02: Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy – Results from a prospective trial – ACOSOG Z1071 (Alliance)

Judy C Boughey, Karla V Ballman, William F Symmans, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, Kelly K Hunt

Cancer Res (2015) 75 (9_Supplement): P2-01-02.

https://doi.org/10.1158/1538-7445.SABCS14-P2-01-02

Published: 01 May 2015

View article titled, Abstract P2-01-02: Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy – Results from a prospective trial – ACOSOG Z1071 (Alliance)

Journal Articles

Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]

Ajeet Gajra, Linda McCall, Hyman B Muss, Harvey J Cohen, Aminah Jatoi, Karla V Ballman, Ann H Partridge, Linda Sutton, Barbara A Parker, Gustav Magrinat, Jaqueline M Lafky, Arti Hurria

Cancer Res (2015) 75 (9_Supplement): P5-15-07.

https://doi.org/10.1158/1538-7445.SABCS14-P5-15-07

Published: 01 May 2015

View article titled, Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]

Journal Articles

Abstract PR4: Biochemical recurrence is not a definitive surrogate endpoint for development of clinically useful predictive models for post-prostatectomy patients

Anamaria Crisan, Elai Davicioni, R. Jeffery Karnes, Robert B. Jenkins, Mercedeh H. Ghadessi, Christine Buerki, Eric J. Bergstrahl, Nicholas Erho, Ismael A. Vergara, Karla V. Ballman, Peter C. Black, Timothy J. Triche

Cancer Res (2012) 72 (4_Supplement): PR4.

https://doi.org/10.1158/1538-7445.PRCA2012-PR4

Published: 09 May 2013

View article titled, Abstract PR4: Biochemical recurrence is not a definitive surrogate endpoint for development of clinically useful predictive models for post-prostatectomy patients

Journal Articles

Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial.

Eric L. Grogan, Stephen A. Deppen, Heidi Chen, Karla V. Ballman, Francys C. Verdial, Melinda C. Aldrich, Paul A. Decker, David H. Harpole, Robert J. Cerfolio, Robert J. Keenan, David R. Jones, Thomas A. D'Amico, Joseph B. Shrager, Bryan F. Meyers, Joe B. Putnam

Cancer Res (2013) 73 (8_Supplement): LB-296.

https://doi.org/10.1158/1538-7445.AM2013-LB-296

Published: 15 April 2013

View article titled, Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial.

Journal Articles

Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer

Hannelore V. Heemers, Lucy J. Schmidt, Zhifu Sun, Kevin M. Regan, S. Keith Anderson, Kelly Duncan, Dan Wang, Song Liu, Karla V. Ballman, Donald J. Tindall

Cancer Res (2011) 71 (5): 1978–1988.

https://doi.org/10.1158/0008-5472.CAN-10-2512

Published: 01 March 2011

View article titled, Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer

Includes: Supplementary data

Journal Articles

P-Glycoprotein–Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock Response

Andrea K. McCollum, Cynthia J. TenEyck, Bridget Stensgard, Bruce W. Morlan, Karla V. Ballman, Robert B. Jenkins, David O. Toft, Charles Erlichman

Cancer Res (2008) 68 (18): 7419–7427.

https://doi.org/10.1158/0008-5472.CAN-07-5175

Published: 14 September 2008

View article titled, P-Glycoprotein–Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock Response

Includes: Supplementary data

Journal Articles

A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

Robert B. Jenkins, Hilary Blair, Karla V. Ballman, Caterina Giannini, Robert M. Arusell, Mark Law, Heather Flynn, Sandra Passe, Sara Felten, Paul D. Brown, Edward G. Shaw, Jan C. Buckner

Cancer Res (2006) 66 (20): 9852–9861.

https://doi.org/10.1158/0008-5472.CAN-06-1796

Published: 17 October 2006

View article titled, A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

Includes: Supplementary data

Journal Articles

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q in human oligodendrogliomas.

Robert B. Jenkins, Hilary Blair, Heather Flynn, Sandra Passe, Mark Law, Karla V. Ballman, Ken Aldape, Caterina Giannini, Jan C. Buckner

Cancer Res (2006) 66 (8_Supplement): 1348.

Published: 15 April 2006

View article titled, A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q in human oligodendrogliomas.

Journal Articles

Identification and characterization of galectin-1 activity in glioblastoma invasion

L. Gerard Toussaint, III, Allan E. Nilson, Jennie M. Goble, Karla V. Ballman, C. David James, Joon H. Uhm

Cancer Res (2006) 66 (8_Supplement): 806.

Published: 15 April 2006

View article titled, Identification and characterization of galectin-1 activity in glioblastoma invasion

Journal Articles

Gene expression profile in glioma cell line A172 after microcell-mediated transfer of chromosome 19

Gaspar J. Kitange, Thomas M. Kollmeyer, Mark Law, Cheryl Soderberg, Kristen L. Templeton, Bruce W. Morlan, Karla V. Ballman, Robert B. Jenkins

Cancer Res (2005) 65 (9_Supplement): 850.

Published: 01 May 2005

View article titled, Gene expression profile in glioma cell line A172 after microcell-mediated transfer of chromosome 19

Journal Articles

A polymorphism in GLTSCR1 is associated with the development of oligodendrogliomas

Robert B. Jenkins, Thomas Kollmeyer, Kristin Buckner, William Bamlet, Karla V. Ballman, Ping Yang

Cancer Res (2004) 64 (7_Supplement): 256.

Published: 01 April 2004

View article titled, A polymorphism in GLTSCR1 is associated with the development of oligodendrogliomas

Journal Articles

Gene expression profile of LNCaP cells treated with the dual 5 alpha-Reductase inhibitor dutasteride

Lucy J. Schmidt, Karla V. Ballman, Bruce W. Morlan, Donald J. Tindall

Cancer Res (2004) 64 (7_Supplement): 447.

Published: 01 April 2004

View article titled, Gene expression profile of LNCaP cells treated with the dual 5 alpha-Reductase inhibitor dutasteride

Journal Articles

B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma

Scott E. Strome, Haidong Dong, Hideto Tamura, Stephen G. Voss, Dallas B. Flies, Koji Tamada, Diva Salomao, John Cheville, Fumiya Hirano, Wei Lin, Jan L. Kasperbauer, Karla V. Ballman, Lieping Chen

Cancer Res (2003) 63 (19): 6501–6505.

Published: 14 October 2003

View article titled, B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma

NARROW

Abstract CT014: Phase I dose-escalation study of fractionated dose 225Ac J591 for metastatic castration resistant prostate cancer

Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)

Abstract 3407: Circulating tumor DNA is associated with response and survival in patients with advanced leiomyosarcoma

Abstract 494: Role of age, BMI, and tumor subtype in racial/ethnic disparities in breast cancer survival: A pooled analysis of four Alliance adjuvant clinical trials

Abstract S1-06: Stromal tumor-infiltrating lymphocytes(S-TILs): In the alliance N9831 trial S-TILs are associated with chemotherapy benefit but not associated with trastuzumab benefit

Abstract P2-01-02: Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy – Results from a prospective trial – ACOSOG Z1071 (Alliance)

Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]

Abstract PR4: Biochemical recurrence is not a definitive surrogate endpoint for development of clinically useful predictive models for post-prostatectomy patients

Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial.

Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer

P-Glycoprotein–Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock Response

A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q in human oligodendrogliomas.

Identification and characterization of galectin-1 activity in glioblastoma invasion

Gene expression profile in glioma cell line A172 after microcell-mediated transfer of chromosome 19

A polymorphism in GLTSCR1 is associated with the development of oligodendrogliomas

Gene expression profile of LNCaP cells treated with the dual 5 alpha-Reductase inhibitor dutasteride

B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only